Skip to main content

Advertisement

SpringerLink
Log in

Establishment of a keratinocyte and fibroblast bank for clinical applications in Japan

  • Original Article
  • Tissue Engineering / Regenerative Medicine
  • Published:
Journal of Artificial Organs Aims and scope Submit manuscript

    We’re sorry, something doesn't seem to be working properly.

    Please try refreshing the page. If that doesn't work, please contact support so we can address the problem.

Abstract

Regenerative medicine products using allogeneic cells, such as allogeneic cultured epidermis (allo-CE), have become a more critical therapeutic method for the treatment of burns. However, there are no clinically available allo-CE products in Japan. Therefore, establishing a quality-controlled cell bank is mandatory to create regenerative medical products using allogeneic cells. In this study, we selected ten patients from the Department of Plastic Surgery of Kyoto University Hospital to become cell donors. We performed medical interviews and blood sampling for the donor to ensure virus safety. We examined the tissues and isolated cells by performing a nucleic acid test (NAT). To establish a master cell bank, quality evaluation was performed according to the International Conference of Harmonization (ICH) Q5A. Serological tests of the blood samples from the ten donors showed that two of them were ineligible. The cells registered in the cell bank were found to be compatible after virus testing was performed, and a master cell bank was constructed. Hence, we established a keratinocyte and fibroblast bank of clinically usable human cultured cells in Japan for the first time.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Berthiaume F, Maguire TJ, Yarmush ML. Tissue engineering and regenerative medicine: History, progress, and challenges. Annu Rev Chem Biomol Eng. 2011;2:403–30. https://doi.org/10.1146/annurev-chembioeng-061010-114257.

    Article  PubMed  Google Scholar 

  2. Sakamoto M, Morimoto N, Inoie M, Takahagi M, Ogino S, Jinno C, et al. Cultured human epidermis combined with meshed skin autografts accelerates epithelialization and granulation tissue formation in a rat model. Ann Plast Surg. 2017;78:651–8. https://doi.org/10.1097/SAP.0000000000001058.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Sakamoto M, Ogino S, Shimizu Y, Inoie M, Lee S, Yamanaka H, et al. Human cultured epidermis accelerates wound healing regardless of its viability in a diabetic mouse model. PLoS ONE. 2020;15: e0237985. https://doi.org/10.1371/journal.pone.0237985.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Madden MR, Finkelstein JL, Staiano-Coico L, Goodwin CW, Shires GT, Nolan EE, et al. Grafting of cultured allogeneic epidermis on second- and third-degree burn wounds on 26 patients. J Trauma. 1986;26:955–62. https://doi.org/10.1097/00005373-198611000-00001.

    Article  CAS  PubMed  Google Scholar 

  5. Hefton JM, Madden MR, Finkelstein JL, Shires GT. Grafting of burn patients with allografts of cultured epidermal cells. Lancet. 1983;2:428–30. https://doi.org/10.1016/s0140-6736(83)90392-6.

    Article  CAS  PubMed  Google Scholar 

  6. De Luca M, Albanese E, Bondanza S, Megna M, Ugozzoli L, Molina F, et al. Multicentre experience in the treatment of burns with autologous and allogenic cultured epithelium, fresh or preserved in a frozen state. Burns. 1989;15:303–9. https://doi.org/10.1016/0305-4179(89)90007-7.

    Article  PubMed  Google Scholar 

  7. van der Merwe AE, Mattheyse FJ, Bedford M, van Helden PD, Rossouw DJ. Allografted keratinocytes used to accelerate the treatment of burn wounds are replaced by recipient cells. Burns. 1990;16:193–7. https://doi.org/10.1016/0305-4179(90)90038-x.

    Article  PubMed  Google Scholar 

  8. De Luca M, Bondanza S, Cancedda R, Tamisani AM, Di Noto C, Muller L, et al. Permanent coverage of full skin thickness burns with autologous cultured epidermis and reepithelialization of partial skin thickness lesions induced by allogeneic cultured epidermis: A multicentre study in the treatment of children. Burns. 1992;18:S16–9. https://doi.org/10.1016/0305-4179(92)90105-4.

    Article  PubMed  Google Scholar 

  9. Teepe RG, Roseeuw DI, Hermans J, Koebrugge EJ, Altena T, de Coninck A, et al. Randomized trial comparing cryopreserved cultured epidermal allografts with hydrocolloid dressings in healing chronic venous ulcers. J Am Acad Dermatol. 1993;29:982–8. https://doi.org/10.1016/0190-9622(93)70278-2.

    Article  CAS  PubMed  Google Scholar 

  10. Phillips TJ, Provan A, Colbert D, Easley KW. A randomized single-blind controlled study of cultured epidermal allografts in the treatment of split-thickness skin graft donor sites. Arch Dermatol. 1993;129:879–82.

    Article  CAS  PubMed  Google Scholar 

  11. Rivas-Torres MT, Amato D, Arámbula-Alvarez H, Kuri-Harcuch W. Controlled clinical study of skin donor sites and deep partial-thickness burns treated with cultured epidermal allografts. Plast Reconstr Surg. 1996;98:279–87. https://doi.org/10.1097/00006534-199608000-00011.

    Article  CAS  PubMed  Google Scholar 

  12. Duinslaeger LA, Verbeken G, Vanhalle S, Vanderkelen A. Cultured allogeneic keratinocyte sheets accelerate healing compared to Op-site treatment of donor sites in burns. J Burn Care Rehabil. 1997;18:545–51. https://doi.org/10.1097/00004630-199711000-00013.

    Article  CAS  PubMed  Google Scholar 

  13. Beele H, Naeyaert JM, Goeteyn M, De Mil M, Kint A. Repeated cultured epidermal allografts in the treatment of chronic leg ulcers of various origins. Dermatologica. 1991;183:31–5. https://doi.org/10.1159/000247628.

    Article  CAS  PubMed  Google Scholar 

  14. Lindgren C, Marcusson JA, Toftgård R. Treatment of venous leg ulcers with cryopreserved cultured allogeneic keratinocytes: a prospective open controlled study. Br J Dermatol. 1998;139:271–5. https://doi.org/10.1046/j.1365-2133.1998.02364.x.

    Article  CAS  PubMed  Google Scholar 

  15. Leigh IM, Purkis PE, Navsaria HA, Phillips TJ. Treatment of chronic venous ulcers with sheets of cultured allogenic keratinocytes. Br J Dermatol. 1987;117:591–7. https://doi.org/10.1111/j.1365-2133.1987.tb07491.x.

    Article  CAS  PubMed  Google Scholar 

  16. Andrews PW, Cavagnaro J, Deans R, Feigal E, Horowitz E, Keating A, et al. Harmonizing standards for producing clinical-grade therapies from pluripotent stem cells. Nat Biotechnol. 2014;32:724–6. https://doi.org/10.1038/nbt.2973.

    Article  CAS  PubMed  Google Scholar 

  17. Heng WL, Wang QW, Sornarajah R, Tremblay J, Putri NM, Hamid SSA, et al. A review of skin banking guidelines and standards worldwide: Towards the harmonization of guidelines for skin banking in therapeutic applications for the regions under the Asia Pacific Burn Association (APBA). Burns Trauma. 2020;8:tkaa019. https://doi.org/10.1093/burnst/tkaa019.

    Article  PubMed  PubMed Central  Google Scholar 

  18. Cobo F, Stacey GN, Hunt C, Cabrera C, Nieto A, Montes R, et al. Microbiological control in stem cell banks: approaches to standardisation. Appl Microbiol Biotechnol. 2005;68:456–66. https://doi.org/10.1007/s00253-005-0062-2.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Ramarli D, Giri A, Reina S, Poffe O, Cancedda R, Varnier O, et al. HIV-1 spreads from lymphocytes to normal human keratinocytes suitable for autologous and allogenic transplantation. J Invest Dermatol. 1995;105:644–7. https://doi.org/10.1111/1523-1747.ep12324100.

    Article  CAS  PubMed  Google Scholar 

  20. Dodd RY, Crowder LA, Haynes JM, Notari EP, Stramer SL, Steele WR. Screening blood donors for HIV, HCV, and HBV at the American Red Cross: 10-year trends in prevalence, incidence, and residual risk, 2007 to 2016. Transfus Med Rev. 2020;34:81–93. https://doi.org/10.1016/j.tmrv.2020.02.001.

    Article  PubMed  Google Scholar 

  21. Stramer SL, Dodd RY. AABB Transfusion-Transmitted Diseases Emerging Infectious Diseases Subgroup. Transfusion-transmitted emerging infectious diseases: 30 years of challenges and progress. Transfusion. 2013;53:2375–83. https://doi.org/10.1111/trf.12371.

    Article  PubMed  PubMed Central  Google Scholar 

  22. Ward JW, Holmberg SD, Allen JR, Cohn DL, Critchley SE, Kleinman SH, et al. Transmission of human immunodeficiency virus (HIV) by blood transfusions screened as negative for HIV antibody. N Engl J Med. 1988;318:473–8. https://doi.org/10.1056/NEJM198802253180803.

    Article  CAS  PubMed  Google Scholar 

  23. Durand F, Beauplet A, Marcellin P. Evidence of hepatitis C virus viremia without detectable antibody to hepatitis C virus in a blood donor. Ann Intern Med. 2000;133:74–5. https://doi.org/10.7326/0003-4819-133-1-200007040-00018.

    Article  CAS  PubMed  Google Scholar 

  24. Glynn SA, Kleinman SH, Schreiber GB, Busch MP, Wright DJ, Smith JW, et al. Trends in incidence and prevalence of major transfusion-transmissible viral infections in US blood donors, 1991 to 1996 Retrovirus Epidemiology Donor Study (REDS). JAMA. 2000;284:229–35. https://doi.org/10.1001/jama.284.2.229.

    Article  CAS  PubMed  Google Scholar 

  25. Stramer SL, Glynn SA, Kleinman SH, Strong DM, Caglioti S, Wright DJ, et al. Detection of HIV-1 and HCV infections among antibody-negative blood donors by nucleic acid-amplification testing. N Engl J Med. 2004;351:760–8. https://doi.org/10.1056/NEJMoa040085.

    Article  CAS  PubMed  Google Scholar 

  26. Takeuchi H, Kobayashi R, Hasegawa M, Hirai K. Detection of latent infection by Epstein-Barr virus in peripheral blood cells of healthy individuals and in non-neoplastic tonsillar tissue from patients by reverse transcription-polymerase chain reaction. J Virol Methods. 1996;58:81–9. https://doi.org/10.1016/0166-0934(95)01993-6.

    Article  CAS  PubMed  Google Scholar 

  27. Cassinotti P, Burtonboy G, Fopp M, Siegl G. Evidence for persistence of human parvovirus B19 DNA in bone marrow. J Med Virol. 1997;53:229–32. https://doi.org/10.1002/(SICI)1096-9071(199711)53:3%3c229::AID-JMV8%3e3.0.CO;2-A.

    Article  CAS  PubMed  Google Scholar 

  28. Garbuglia AR, Iezzi T, Capobianchi MR, Pignoloni P, Pulsoni A, Sourdis J, et al. Detection of TT virus in lymph node biopsies of B-cell lymphoma and Hodgkin’s disease, and its association with EBV infection. Int J Immunopathol Pharmacol. 2003;16:109–18. https://doi.org/10.1177/039463200301600204.

    Article  CAS  PubMed  Google Scholar 

  29. Fanci R, De Santis R, Zakrzewska K, Paci C, Azzi A. Presence of TT virus DNA in bone marrow cells from hematologic patients. New Microbiol. 2004;27:113–7.

    CAS  PubMed  Google Scholar 

  30. Arnold DM, Neame PB, Meyer RM, Soamboonsrup P, Luinstra KE, O’Hoski P, et al. Autologous peripheral blood progenitor cells are a potential source of parvovirus B19 infection. Transfusion. 2005;45:394–8. https://doi.org/10.1111/j.1537-2995.2005.04267.x.

    Article  PubMed  Google Scholar 

  31. Suthar MS, Diamond MS, Gale MJ. West Nile virus infection and immunity. Nat Rev Microbiol. 2013;11:115–28. https://doi.org/10.1038/nrmicro2950.

    Article  CAS  PubMed  Google Scholar 

  32. Zou S, Dodd RY, Stramer SL, Strong DM. Tissue Safety Study Group. Probability of viremia with HBV, HCV, HIV, and HTLV among tissue donors in the United States. N Engl J Med. 2004;351:751–9. https://doi.org/10.1056/NEJMoa032510.

    Article  CAS  PubMed  Google Scholar 

  33. Drexler HG, Uphoff CC. Mycoplasma contamination of cell cultures: Incidence, sources, effects, detection, elimination, prevention. Cytotechnology. 2002;39:75–90. https://doi.org/10.1023/A:1022913015916.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  34. Roush DJ. Integrated viral clearance strategies-reflecting on the present, projecting to the future. Curr Opin Biotechnol. 2018;53:137–43. https://doi.org/10.1016/j.copbio.2018.01.003.

    Article  CAS  PubMed  Google Scholar 

  35. Moravvej H, Abdollahimajd F, Naseh MH, Piravar Z, Abolhasani E, Mozafari N, et al. Cultured allogeneic fibroblast injection vs. fibroblasts cultured on amniotic membrane scaffold for dystrophic epidermolysis bullosa treatment. Br J Dermatol. 2018;179:72–9. https://doi.org/10.1111/bjd.16338.

    Article  CAS  PubMed  Google Scholar 

  36. Sakamoto M, Nakano T, Tsuge I, Yamanaka H, Katayama Y, Shimizu Y, et al. Dried human cultured epidermis accelerates wound healing in diabetic mouse skin defect wounds. Sci Rep. 2022;12(1):3184. https://doi.org/10.1038/s41598-022-07156-w.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  37. Brohlin M, Kingham PJ, Novikova LN, Novikov LN, Wiberg M. Aging effect on neurotrophic activity of human mesenchymal stem cells. PLoS ONE. 2012;7: e45052. https://doi.org/10.1371/journal.pone.0045052.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  38. Ferri C, Zakrzewska K, Longombardo G, Giuggioli D, Storino FA, Pasero G, et al. Parvovirus B19 infection of bone marrow in systemic sclerosis patients. Clin Exp Rheumatol. 1999;17:718–20.

    CAS  PubMed  Google Scholar 

  39. Lundqvist A, Isa A, Tolfvenstam T, Kvist G, Broliden K. High frequency of parvovirus B19 DNA in bone marrow samples from rheumatic patients. J Clin Virol. 2005;33:71–4. https://doi.org/10.1016/j.jcv.2004.11.011.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

The authors would like to thank Rie Tatsumi, Minako Chaya, and Yasuko Minaki for their generous assistance.

Funding

This research was supported by the Japan Agency for Medical Research and Development (AMED) under Grant Number JP17be0104005.

Author information

Authors and Affiliations

  1. Department of Plastic and Reconstructive Surgery, Graduate School of Medicine, Kyoto University, 54 Shogoin-Kawaharacho, Sakyo-ku, Kyoto, 6068507, Japan

    Takashi Nakano, Yasuhiro Katayama, Michiharu Sakamoto, Hiroki Yamanaka, Itaru Tsuge, Susumu Saito & Naoki Morimoto

  2. Japan Tissue Engineering, Co., Ltd, Gamagori, Japan

    Yoshihiro Shimizu & Masukazu Inoie

  3. Tokyo Medical and Dental University, Tokyo, Japan

    Norio Shimizu

Authors
  1. Takashi Nakano
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yasuhiro Katayama
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Michiharu Sakamoto
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Yoshihiro Shimizu
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Masukazu Inoie
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Norio Shimizu
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Hiroki Yamanaka
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Itaru Tsuge
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Susumu Saito
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Naoki Morimoto
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Yasuhiro Katayama.

Ethics declarations

Conflict of interest

The authors declare no conflicts of interest.

Ethical approval

Our study was approved by the Ethics Committee at our institute (No. R0690).

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Nakano, T., Katayama, Y., Sakamoto, M. et al. Establishment of a keratinocyte and fibroblast bank for clinical applications in Japan. J Artif Organs 26, 45–52 (2023). https://doi.org/10.1007/s10047-022-01331-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10047-022-01331-6

Keywords

Search

Navigation